Compounds > 9,10-dimethyl-1,2-benzanthracene
Page last updated: 2024-08-17

9,10-dimethyl-1,2-benzanthracene and Leukemia, Myeloid, Acute

9,10-dimethyl-1,2-benzanthracene has been researched along with Leukemia, Myeloid, Acute in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Birtwistle, J; Bunce, CM; Chipman, JK; Davies, NJ; Green, RM; Hayden, RE; Khanim, FL; Pearce, C; Ride, JP; Schrewe, H; Wake, N1
Fischer, R; Fohlmeister, I; Schaefer, HE1
Hagenbeek, A; Martens, AC1
Ioachim, HL; Keller, SE; Pearse, A1
Fujiki, H; Hirota, M; Nakayasu, M; Ojika, M; Suganuma, M; Sugimura, T; Suguri, H; Wakamatsu, K; Yamada, K; Yoshizawa, S1

Other Studies

5 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Leukemia, Myeloid, Acute

ArticleYear
The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: implications for leukemogenesis.
    Mutation research, 2009, Mar-09, Volume: 662, Issue:1-2

    Topics: 3-Hydroxysteroid Dehydrogenases; 9,10-Dimethyl-1,2-benzanthracene; Aldo-Keto Reductase Family 1 Member C3; Cell Differentiation; Cell Line, Tumor; DNA Damage; Gene Expression Regulation, Leukemic; Gene Knockdown Techniques; Glycophorins; Hemoglobins; Humans; Hydroxyprostaglandin Dehydrogenases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Oxidative Stress; Stem Cells

2009
[Pathogenetic relation of hypoplastic myelopathy and preleukemia syndromes].
    Verhandlungen der Deutschen Gesellschaft fur Pathologie, 1983, Volume: 67

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bone Marrow Diseases; Female; Humans; Leukemia, Experimental; Leukemia, Myeloid, Acute; Male; Megakaryocytes; Middle Aged; Preleukemia; Rats; Rats, Inbred Strains; Retrospective Studies; Syndrome

1983
The pathogenesis of a rat model for human acute myelocytic leukemia.
    Haematologica, 1980, Volume: 65, Issue:3

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bone Marrow; Disease Models, Animal; Humans; Leukemia, Experimental; Leukemia, Myeloid, Acute; Male; Neoplasm Transplantation; Rats; Rats, Inbred BN

1980
Role of immune mechanisms in metastatic patterns of hemopoietic tumors in rats.
    Cancer research, 1976, Volume: 36, Issue:8

    Topics: 9,10-Dimethyl-1,2-benzanthracene; AKR murine leukemia virus; Animals; Antibody Formation; Antigens, Neoplasm; Leukemia, Myeloid, Acute; Lymphoma; Neoplasm Metastasis; Neoplasms, Experimental; Organ Specificity; Rats

1976
Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter.
    Proceedings of the National Academy of Sciences of the United States of America, 1988, Volume: 85, Issue:6

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Enzyme Induction; Ethers, Cyclic; Humans; Leukemia, Myeloid, Acute; Lyngbya Toxins; Mice; Okadaic Acid; Ornithine Decarboxylase; Porifera; Protein Kinase C; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured

1988